Sentiss Pharma Private Limited — Vati Exporter Profile
Indian Pharmaceutical Exporter · #6 for Vati · $854.2K export value · DGFT Verified
Sentiss Pharma Private Limited is the #6 Indian exporter of Vati with $854.2K in export value and 36 verified shipments. Sentiss Pharma Private Limited holds a 3.2% market share in Vati exports across 3 countries. The company exports 6 pharmaceutical products worth $28.3M across 4 therapeutic categories.
Sentiss Pharma Private Limited — Vati Export Profile: Buyers & Destinations
Where Does Sentiss Pharma Private Limited Export Vati?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $583.7K | 19 | 65.5% |
| RUSSIA | $299.1K | 19 | 33.6% |
| MALAYSIA | $7.7K | 2 | 0.9% |
Sentiss Pharma Private Limited exports Vati to 3 countries. The largest destination is UNITED KINGDOM accounting for 65.5% of Sentiss Pharma Private Limited's Vati shipments, followed by RUSSIA (33.6%) and MALAYSIA (0.9%). These destinations reflect Sentiss Pharma Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vati from Sentiss Pharma Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDICOM HEALTHCARE LIMITED | UNITED KINGDOM | $533.7K | 18 |
| LLC SENTISS RUS | RUSSIA | $264.9K | 16 |
| BLUMONT HEALTHCARE LIMITED | UNITED KINGDOM | $50.0K | 1 |
| LLC ?SENTISS RUS? | RUSSIA | $34.2K | 3 |
| UNIMED SDN BHD | MALAYSIA | $7.7K | 2 |
Sentiss Pharma Private Limited supplies Vati to 5 buyers globally. The largest buyer is MEDICOM HEALTHCARE LIMITED (UNITED KINGDOM), followed by LLC SENTISS RUS (RUSSIA) and BLUMONT HEALTHCARE LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vati Export Value and How Much Does Sentiss Pharma Private Limited Contribute?
India exported $16.4M worth of Vati through 5,725 shipments from 427 suppliers to 141 countries, serving 869 buyers globally. Sentiss Pharma Private Limited contributes $854.2K to this total, accounting for 3.2% of India's Vati exports. Sentiss Pharma Private Limited ships Vati to 3 countries through 5 buyers.
What Is the Average Shipment Value for Sentiss Pharma Private Limited's Vati Exports?
Sentiss Pharma Private Limited's average Vati shipment value is $23.7K per consignment, based on 36 shipments totaling $854.2K. The largest destination is UNITED KINGDOM (65.5% of Sentiss Pharma Private Limited's Vati exports).
How Does Sentiss Pharma Private Limited Compare to Other Indian Vati Exporters?
Sentiss Pharma Private Limited ranks #6 among 427 Indian Vati exporters with a 3.2% market share. The top 3 exporters are MANKIND PHARMA LIMITED ($4.1M), MICRO LABS LIMITED ($2.5M), EUGIA PHARMA SPECIALITIES LIMITED ($2.0M). Sentiss Pharma Private Limited processed 36 shipments to 3 destination countries.
What Vati Formulations Does Sentiss Pharma Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| XAILIN FRESH (CARMELLOSE 0.5% W/V EYE DROPS PRESERVATIVE FREE 30X0.4ML SINGLESDOSE UNIT UPOC 01705117MPSET | $78.1K | 3 |
| OPTHOLIQUE BK eye drops(without preservative)vial dropper 0.4ml No.20 Bar#8901236018383Salt#polyvinyl ahlchol-14mg povid | $60.1K | 4 |
| XAILIN FRESH CARMELLOSE 0.5% W/V EYE DROPS PRESERVATIVE FREE 30X0.4ML SINGLES DOSE UNIT UPOC 01705117MPPCS | $53.7K | 3 |
| Xailin Fresh Carmellose 0.5% w v Eye Drops Eye Drops Preservative Free 30x0.4ml Singles Dose Unit UPOC 01705117M | $50.0K | 1 |
| XAILIN FRESH CARMELLOSE 0.5% W/V EYE DROPS PRESERVATIVE FREE 30X0.4ML SINGLES DOSE UNIT UPOC 01705117MP | $50.0K | 1 |
| CARMELLOSE SODIUM 0.5% W/V EYE DROPS PRESERVATIVE FREE 30X0.4ML SINGLES DOES UNIT (BATCH NO. : N25032 MFG. DA | $50.0K | 1 |
| XAILIN FRESH(CARMELLOSE 0.5%W/V EYE DROPS PRESERVATIVE FREE30X0.4ML(CE 2460) B NO.N25083,N25084 MFG-03/2025 EXP 02/2027 | $50.0K | 1 |
| OPTHOLIQUE BK DROPS(WITHOUT PRESERVATIVE | $45.0K | 2 |
| OPTHOLIQUE BK EYE DROPSWITHOUT PRESRVATIVEVIAL DROPPER 0.4ML NO.20,BAR#8901236018383,SALT#POLYVINYL AHLCOHOL-14MG**** | $40.1K | 1 |
| XAILIN FRESH (CARMELLOSE 0.5% W/V EYE DROPS) PRESERVATIVE FREE 30X0.4ML SINGLESDOSE UNIT UPOC01705117MPSET | $39.2K | 1 |
Sentiss Pharma Private Limited exports 28 distinct Vati formulations including tablets, capsules, syrups, and combination drugs. The top formulation is XAILIN FRESH (CARMELLOSE 0.5% W/V EYE DROPS PRESERVATIVE F with 3 shipments worth $78.1K.
Regulatory Requirements: Exporting Vati to Key Markets
What Sentiss Pharma Private Limited must comply with to export Vati to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sentiss Pharma Private Limited Compare to Nearest Vati Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | LABORATE PHARMACEUTICALS INDIA LTD | $1.9M | 215 | 18 | $8.7K |
| 5 | MSN LABORATORIES PRIVATE LIMITED | $1.3M | 45 | 3 | $28.2K |
| 6 | SENTISS PHARMA PRIVATE LIMITED ★ | $854.2K | 36 | 3 | $23.7K |
| 8 | STERICON PHARMA PRIVATE LIMITED | $639.5K | 15 | 3 | $42.6K |
| 9 | GEPACH INTERNATIONAL | $624.1K | 22 | 3 | $28.4K |
Sentiss Pharma Private Limited ranks #6 among 427 Indian Vati exporters. Average shipment value of $23.7K compared to the market average of $38.3K. The closest competitors by value are LABORATE PHARMACEUTICALS INDIA LTD and MSN LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Vati Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 1,284 | 22.4% |
| DELHI AIR | 1,026 | 17.9% |
| SAHAR AIR | 379 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 306 | 5.3% |
| NHAVA SHEVA SEA (INNSA1) | 179 | 3.1% |
| PATLI ICD | 171 | 3.0% |
| Delhi Air | 170 | 3.0% |
| Delhi Air Cargo | 141 | 2.5% |
Geopolitical & Trade Policy Impact on Sentiss Pharma Private Limited's Vati Exports
Recent geopolitical tensions have significantly impacted global shipping routes, affecting Indian pharmaceutical exporters like Sentiss Pharma. The Israel-Iran conflict has led to heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute vessels around the Cape of Good Hope. This diversion has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes. (livemint.com)
Additionally, the U.S. has imposed tariffs on pharmaceutical imports, aiming to reduce reliance on foreign generics. While Indian manufacturers supply a significant portion of U.S. generics, tariffs exceeding 10–15% could lead to market exits due to thin profit margins, potentially disrupting supply chains. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive requires stringent quality controls and traceability measures. For companies like Sentiss, adhering to these regulations is crucial to maintain market access and competitiveness.
Sentiss Pharma Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set stringent quality benchmarks. Non-compliance can lead to import bans and reputational damage, as seen in past instances where Indian companies faced restrictions due to quality issues. (comcec.org)
Sentiss Pharma's acquisition of Akorn AG, with its U.S. FDA-approved facility, indicates a commitment to meeting these high standards. This strategic move not only enhances manufacturing capabilities but also ensures adherence to regulatory requirements in key markets. (crisilratings.com)
About Sentiss Pharma Private Limited
Sentiss Pharma Private Limited exports 6 products worth $28.3M. Beyond Vati, top products include Ciprofloxacin, Ofloxacin, Levofloxacin, Dexamethasone, Tobramycin. View the complete Sentiss Pharma Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vati — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vati shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sentiss Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 40 individual customs records matching Sentiss Pharma Private Limited exporting Vati, covering 28 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 869+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vati Export Data from Sentiss Pharma Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sentiss Pharma Private Limited's Vati exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sentiss Pharma Private Limited
Full Company Profile →
6 products · $28.3M total trade · 4 categories
Vati Stats
Company Overview
Top Products by Sentiss Pharma Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sentiss Pharma Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vati. For current shipment-level data, contact TransData Nexus.